The Syn-Sleep Study

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

December 17, 2025

Study Completion Date

December 31, 2025

Conditions
REM Sleep Behavior Disorder (iRBD)
Interventions
DIAGNOSTIC_TEST

Syn-One Test

Participating subjects will have three small skin punch biopsies.

Trial Locations (8)

10003

Mount Sinai, New York

40536

University of Kentucky, Lexington

75092

Texas Institute for Neurological Disorders, Sherman

85006

Banner Health, Phoenix

85258

CND Life Sciences, Scottsdale

85286

MD First Research, Chandler

90048

Cedars Sinai Medical Center, Los Angeles

94304

Stanford Neuroscience Health Center, Palo Alto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CND Life Sciences

OTHER

NCT05757206 - The Syn-Sleep Study | Biotech Hunter | Biotech Hunter